Abadan, Romel G.
HRN: 20-83-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
CEFTRIAXONE 1G (VIAL)
01/30/2023
02/06/2023
IV
425mg
Q12
AGE With Mod DHN; Hypokalemia
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes